Clinical Trials at Major University; New Application Targeting Cancer Tumors; IP Portfolio with 9 Patents: NASDAQ: RNXT
New Application Targeting Tumors with an IP Portfolio of 9 Patents Issued, 9 Pending for Cancer Treatments Partnered with Imugene: RenovoRx (NASDAQ: RNXT) RenovoRx, Inc. (NASDAQ:RNXT) LOS ALTOS, CALIFORNIA, UNITED STATES, December 28, 2023 / …